© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Product Name: Tabletas Inhibidoras de Proteasa
Synonyms: Potent HIV Protease Inhibitor Tablets
Recommended Use: Oral pharmaceutical for prescribed treatment of viral infections
Manufacturer: PharmaSalud S.A.
Emergency Contact: +52 800 123 4567 (24 Hour Emergency Hotline)
Product Code: TSIP-10
Supplier Address: Calle Salud 456, CDMX, México
Date of Issue: 2024-03-15
Classification: Not classified as hazardous according to GHS for normal handling, considered a pharmaceutical product and not intended for general public use without prescription.
Acute Health Hazards: May cause mild gastrointestinal irritation if ingested in large quantities, may provoke allergies in sensitized individuals.
Chronic Health Hazards: Potential liver or kidney effects with chronic overexposure, based on animal studies of similar compounds.
Environmental Hazards: Possible risk to aquatic life if large quantities are released untreated into waterways.
Label Elements: No pictogram required; precaution word: WARNING
Precautionary Statements: Avoid ingestion above recommended dose, keep out of reach of children.
Active Ingredient: Ritonavir, 100 mg per tablet
Chemical Abstracts Number (CAS): 155213-67-5
Inactive Ingredients: Microcrystalline cellulose (CAS 9004-34-6), lactose monohydrate (CAS 10039-26-6), magnesium stearate (CAS 557-04-0), colloidal silicon dioxide (CAS 7631-86-9), pregelatinized starch (CAS 9005-25-8), povidone (CAS 9003-39-8)
Impurities and Stabilizers: Maximum impurity level set below 0.1%
Physical State: Solid, oral tablet form, white to off-white
Inhalation: Move exposed person to fresh air, seek medical advice if symptoms like cough or difficulty breathing appear.
Skin Contact: Wash area with plenty of soap and water, remove contaminated clothing, consult a doctor upon skin reaction.
Eye Contact: Rinse eyes with clean running water for minimum 15 minutes, get medical attention if irritation occurs.
Ingestion: Rinse mouth thoroughly, do not induce vomiting, seek immediate medical advice and show product label.
Note for Physicians: Symptomatic treatment, address allergic reactions or accidental overdose per clinical protocol.
Suitable Extinguishing Media: Water spray, dry chemical, foam, or CO2
Unsuitable Extinguishing Media: Strong water jet may spread spilled tablets or powder
Hazards from Combustion: May emit nitrogen oxides, carbon monoxide and other toxic fumes
Special Protective Actions: Firefighters should wear full protective gear including self-contained breathing apparatus
Special Procedures: Prevent runoff into drains or watercourses as small powder particles may persist environmentally.
Personal Precautions: Avoid contact with skin and eyes, wear gloves, mask and protective clothing
Environmental Precautions: Prevent tablets and dust from entering sewage systems or open water
Method for Cleaning Up: Pick up tablets carefully, collect powder with a damp paper towel and place in a sealed bag, ventilate area, clean surfaces with soap and water after spill
Waste Disposal: Place collected waste in accordance with local regulations for pharmaceutical waste
Handling: Handle with clean, dry hands, avoid crushing or breaking tablets unless indicated by a healthcare provider, avoid generation of powder
Safe Storage Conditions: Store at temperatures between 15 and 30ºC, protect from light and moisture, keep tightly closed in original container
Other Precautions: Keep away from food and drink, keep out of reach of unauthorized persons, use only as prescribed
Incompatibilities: Strong oxidizers, strong acids, and bases
Occupational Exposure Limits: No specific OSHA or NIOSH TLV established for ritonavir in tablet form
Engineering Controls: Use local exhaust ventilation to avoid airborne dust during manufacturing or compounding
Personal Protection for Bulk Handling: Gloves (nitrile), lab coat, dust mask or N95 respirator, safety glasses
Hygiene Measures: Wash hands and face after handling, do not eat or drink in work area
Physical State: Compressed solid tablets
Appearance: White to off-white, round, film-coated
Odor: Slight medicinal odor
Solubility: Sparingly soluble in water
Melting Point (Active): ~120°C
Boiling Point: Not applicable (solid at ambient temperature)
pH (1% suspension): 4.0 - 5.0
Vapor Pressure: Not applicable
Relative Density: ~1.2
Chemical Stability: Stable under recommended storage conditions
Reactivity: No hazardous reactions under normal handling and storage
Hazardous Decomposition Products: Possibility of producing irritating or toxic gases under fire conditions
Materials to Avoid: Keep away from strong acids, bases and sugars when storing in bulk
Polymerization: No risk of hazardous polymerization
Acute Toxicity: Estimated oral LD50 (rat): >2000 mg/kg for main ingredient
Common Symptoms: Headache, nausea, diarrhea, stomach pain with overdose
Chronic Effects: Effects on liver or kidney at high exposure levels over time, as reported in animal studies and some treated humans
Allergenicity: Allergy reported rarely with pharmaceutical use
Mutagenicity and Carcinogenicity: Not classified as mutagenic or carcinogenic by IARC or NTP per available data
Ecotoxicity: Active ingredient is slightly toxic to aquatic life, chronic exposure could disrupt aquatic communities if present in high concentrations
Degradability: Slow degradation in environment, breakdown primarily by microbial activity
Bioaccumulation Potential: Low; does not tend to accumulate in aquatic organisms
Water Quality Impact: Proper wastewater treatment reduces risk of environmental release
Other Environmental Notes: Avoid uncontrolled disposal or large-scale release
Product Waste: Collect unused or expired tablets as hazardous pharmaceutical waste, follow all local environmental regulations
Container Disposal: Empty containers should be triple rinsed before recycling or disposal, follow local protocols for sharps or pharma packaging
Incineration: Suitable for high-temperature incineration in approved facility
Do Not: Flush tablets or powder into household waste or water systems
UN Number: Not regulated for transport in packaged pharmaceutical form
Proper Shipping Name: Medicinal product, not otherwise specified
Transport Hazard Class: None required
Packing Group: Not assigned
Special Precautions: Avoid excess heat or moisture during shipment, transport in original packaging
Labels: Not required for non-bulk shipments
GHS Compliance: Compliant, not classified as hazardous for finished tablets
US FDA: Approved for specific indications; prescription only
Mexico COFEPRIS: Classified as a controlled pharmaceutical product
SARA/OSHA Status: Not listed as hazardous under SARA Title III, not regulated as a workplace chemical
EC Regulations: Listed in EINECS inventory, not classified as hazardous for finished medicinal product
Labeling: Pharmaceutical labeling in accordance with local health authorities' requirements
